Black Diamond Therapeutics (BDTX) Times Interest Earned (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Times Interest Earned of -$9.88 for Q1 2026, up 36.06% on a QoQ basis from -$15.46 in Q4 2025, and down 120.1% year-over-year from $49.17 in Q1 2025.
Black Diamond Therapeutics (BDTX) Times Interest Earned (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$9.88 for Q1 2026.
- Quarterly Times Interest Earned fell 120.1% year-over-year to -$9.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.85 (down 1195.11% YoY) and the FY2025 annual result came in at $0.1, up 116.32% from the prior year.
- Times Interest Earned was -$9.88 for Q1 2026 at Black Diamond Therapeutics, up from -$15.46 in the prior quarter.
- Across five years, Times Interest Earned topped out at $49.17 in Q1 2025 and bottomed at -$36.58 in Q1 2022.
- A 5-year average of -$8.42 and a median of -$9.88 in 2026 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 362.29% in 2025, while the deepest fall reached 2833.33% in 2025.
- Black Diamond Therapeutics' Times Interest Earned stood at -$20.79 in 2022, then advanced by 7.13% to -$19.31 in 2023, then advanced by 14.66% to -$16.48 in 2024, then rose by 6.18% to -$15.46 in 2025, then soared by 36.06% to -$9.88 in 2026.
- Business Quant data shows BDTX's Times Interest Earned at -$9.88 in Q1 2026, -$15.46 in Q4 2025, and -$1.99 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -9.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.88 |
| Dec 31, 2025 | -15.46 |
| Sep 30, 2025 | -1.99 |
| Jun 30, 2025 | -22.98 |
| Mar 31, 2025 | 49.17 |
| Dec 31, 2024 | -16.48 |
| Sep 30, 2024 | -2.46 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -18.75 |
| Dec 31, 2023 | -19.31 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -1.77 |
| Mar 31, 2023 | -20.51 |
| Dec 31, 2022 | -20.79 |
| Sep 30, 2022 | -0.62 |
| Jun 30, 2022 | -3.19 |
| Mar 31, 2022 | -36.58 |
| Dec 31, 2021 | -43.18 |
| Sep 30, 2021 | -4.20 |
| Jun 30, 2021 | -1.94 |